Literature DB >> 27432077

Managing hypertension in type 2 diabetes mellitus.

Samuel Horr1, Steven Nissen2.   

Abstract

Hypertension is a common problem in the diabetic population with estimates suggesting a prevalence exceeding 60%. Comorbid hypertension and diabetes mellitus are associated with high rates of macrovascular and microvascular complications. These two pathologies share overlapping risk factors, importantly central obesity. Treatment of hypertension is unequivocally beneficial and improves all-cause mortality, cardiovascular mortality, major cardiovascular events, and microvascular outcomes including nephropathy and retinopathy. Although controversial, current guidelines recommend a target blood pressure in the diabetic population of <140/90 mmHg, which is a similar target to that proposed for individuals without diabetes. Management of blood pressure in patients with diabetes includes both lifestyle modifications and pharmacological therapies. This article reviews the evidence for management of hypertension in patients with type 2 diabetes mellitus, and provides a recommended treatment strategy based on the available data.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  diabetes mellitus; hypertension; pharmacology

Mesh:

Substances:

Year:  2016        PMID: 27432077     DOI: 10.1016/j.beem.2016.06.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  9 in total

Review 1.  Blood pressure management in patients with type 2 diabetes mellitus.

Authors:  Hisashi Kai
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

2.  Blood Pressure Control and Other Quality of Care Metrics for Patients with Obesity and Diabetes: A Population-Based Cohort Study.

Authors:  Jennifer T Fink; Elizabeth M Magnan; Heather M Johnson; Lauren M Bednarz; Glenn O Allen; Robert T Greenlee; Daniel M Bolt; Maureen A Smith
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-10-16

3.  Fimasartan Ameliorates Deteriorations in Glucose Metabolism in a High Glucose State by Regulating Skeletal Muscle and Liver Cells.

Authors:  Yoo Na Jang; Yong Jik Lee; Yoon Mi Han; Hyun Min Kim; Hong Seog Seo; Ji Hoon Jeong; Seung Yeon Park; Tae Woo Jung
Journal:  Yonsei Med J       Date:  2022-06       Impact factor: 3.052

4.  Trajectories: a framework for detecting temporal clinical event sequences from health data standardized to the Observational Medical Outcomes Partnership (OMOP) Common Data Model.

Authors:  Kadri Künnapuu; Solomon Ioannou; Kadri Ligi; Raivo Kolde; Sven Laur; Jaak Vilo; Peter R Rijnbeek; Sulev Reisberg
Journal:  JAMIA Open       Date:  2022-03-16

5.  Nonalcoholic Fatty Liver Disease and Associated Metabolic Risks of Hypertension in Type 2 Diabetes: A Cross-Sectional Community-Based Study.

Authors:  Xiaoying Ding; Ying Xu; Yufan Wang; Xiaohua Li; Chunhua Lu; Jing Su; Yuhang Ma; Yuting Chen; Yanhua Yin; Lijun Zhang; Yong Wu; Yaqiong Jin; Lijun Zheng; Songmei Xu; Xiuli Zhu; Jilin Ma; Lihua Yu; Junyi Jiang; Naisi Zhao; Qingwu Yan; Andrew S Greenberg; Qianfang Huang; Qian Ren; Haiyan Sun; Mingyu Gu; Li Zhao; Yunhong Huang; Yijie Wu; Chunxian Qian; Yongde Peng
Journal:  Int J Endocrinol       Date:  2017-03-26       Impact factor: 3.257

Review 6.  Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.

Authors:  Xiaojun Feng; Antoni Sureda; Samineh Jafari; Zahra Memariani; Devesh Tewari; Giuseppe Annunziata; Luigi Barrea; Sherif T S Hassan; Karel Šmejkal; Milan Malaník; Alice Sychrová; Davide Barreca; Lovro Ziberna; Mohamad Fawzi Mahomoodally; Gokhan Zengin; Suowen Xu; Seyed Mohammad Nabavi; Ai-Zong Shen
Journal:  Theranostics       Date:  2019-03-16       Impact factor: 11.556

7.  Analyzing Complexity and Fractality of Glucose Dynamics in a Pregnant Woman with Type 2 Diabetes under Treatment.

Authors:  Xiaoyan Chen; Dandan Wang; Jinxiang Lin; Teng Zhang; Shunyou Deng; Lianyi Huang; Yu Jin; Chang Chen; Zhaozhi Zhang; Jun Zheng; Baoqing Sun; Paul Bogdan; Xiaohua Douglas Zhang
Journal:  Int J Biol Sci       Date:  2019-09-07       Impact factor: 6.580

8.  Increased Mortality Trends in Patients With Chronic Non-communicable Diseases and Comorbid Hypertension in the United States, 2000-2019.

Authors:  Feiyun Ouyang; Xunjie Cheng; Wei Zhou; Jun He; Shuiyuan Xiao
Journal:  Front Public Health       Date:  2022-07-11

9.  Diabetes and Covid-19: An interplay difficult to dissect.

Authors:  Raffaele Napoli
Journal:  Diabetes Metab Res Rev       Date:  2020-08-20       Impact factor: 4.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.